Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.59 |
| ▸ | CALCR | P30988 | 3/20 | 0.56 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.56 |
| ▸ | GLP1R | P43220 | 1/20 | 0.54 |
| ▸ | GCGR | P47871 | 1/20 | 0.54 |
| ▸ | GIPR | P48546 | 1/20 | 0.54 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.53 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.53 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29714704 | 0.97 | BACE1 (0.57) | BACE1CALCRVIPR1GLP1RGCGR | |
| SCHEMBL30903279 | 0.92 | BACE1 (0.62) | BACE1CALCRVIPR1GLP1RGCGR | |
| SCHEMBL30512733 | 0.92 | BACE1 (0.63) | BACE1PTH1R | |
| SCHEMBL30512687 | 0.91 | BACE1 (0.56) | BACE1CALCRVIPR1KISS1RVIPR2 | |
| SCHEMBL29714699 | 0.89 | BACE1 (0.54) | BACE1CALCRGLP1RGCGRGIPR | |
| SCHEMBL31182917 | 0.89 | BACE1 (0.57) | BACE1VIPR1GLP1RGCGRGIPR | |
| SCHEMBL38664588 | 0.89 | BACE1 (0.68) | BACE1CALCRVIPR1GLP1RGCGR | |
| SCHEMBL29867734 | 0.88 | VIPR1 (0.58) | BACE1VIPR1GLP1RKISS1RVIPR2 | |
| SCHEMBL31182757 | 0.88 | VIPR1 (0.64) | BACE1VIPR1GLP1RKISS1RVIPR2 | |
| SCHEMBL30903273 | 0.88 | VIPR1 (0.64) | BACE1VIPR1GLP1RKISS1RVIPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11597757-B2 | Peptide for treating cancer | SAINT LEO UNIVERSITY (US) | 2023-03-07 | — | — | US | claimed |
| EP-4034243-A2 | PEPTIDE FOR TREATING CANCER | Saint Leo University (US) | 2022-08-03 | — | — | EP | claimed |
| US-12297295-B2 | Peptide for treating cancer | SAINT LEO UNIVERSITY (US) | 2025-05-13 | — | — | US | disclosed |
| US-11597757-B2 | Peptide for treating cancer | SAINT LEO UNIVERSITY (US) | 2023-03-07 | — | — | US | disclosed |
| US-11597757-B2 | Peptide for treating cancer | SAINT LEO UNIVERSITY (US) | 2023-03-07 | — | — | US | disclosed |
| EP-4034243-A2 | PEPTIDE FOR TREATING CANCER | Saint Leo University (US) | 2022-08-03 | — | — | EP | disclosed |
| EP-4034243-A2 | PEPTIDE FOR TREATING CANCER | Saint Leo University (US) | 2022-08-03 | — | — | EP | disclosed |